Stock Message Board Recent Posts http://investorshangout.com/search?q=LGNXZ&am...mp;yt0=Go!
Last Updated: 08/06/2014 11:26:02
Current Price and Quotes
Last Price 0.115
Previous Close 0.115 Open N/A
Daily Range N/A - N/A 52wk Range 0.10 - 0.2049
Volume 0 Dividend N/A
Average Vol (3m) 13,824 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 48,973 31,388 30,037 23,538
Cost of Revenue 5,732 3,601 4,909 -
Gross Profit 43,241 27,787 25,128 23,538
Operating Expenses
Research and Development 9,274 10,790 10,291 22,067
Sales, General and Admin. 17,984 15,782 12,881 11,127
Non-Recurring Items 1,040 1,022 2,834 19,648
Other - - - -
Operating Income 14,943 193 (878) (29,304)
Income From Continuing Operations
Add'l Income/Expense Items (3,660) (1,134) (383) 13,519
Earnings Before Interest and Tax 11,283 (941) (1,261) (15,403)
Interest Expense 2,077 2,924 2,297 -
Earnings Before Tax 9,206 (3,865) (3,558) (15,403)
Income Tax 374 (1,191) (13,270) (2,617)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 8,832 (2,674) 9,712 (12,786)
Non Recurring Events
Discontinued Operations 2,588 2,147 3 2,413
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 11,420 (527) 9,715 (10,373)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 11,420 (527) 9,715 (10,373)
Recent News
Aug 4, 2014 Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
Aug 4, 2014 Ligand Reports Second Quarter 2014 Financial Results
Jul 30, 2014 The Federal Reserve Playing Analyst Damaging to Biotechnology Companies
Jul 23, 2014 Ligand Partner GSK Announces Record Quarterly Promacta(TM)/Revolade(TM) Revenue of $92 Million
Jul 22, 2014 Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus
Jul 17, 2014 Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund
Jul 17, 2014 Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program
Jul 14, 2014 Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum
Jul 8, 2014 Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne
Jul 7, 2014 Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report
1
2
3
next >
LGNXZ Ligand Pharmaceuticals Incorporated Research DD Guide
Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/LGNXZ/quote
Stock Chart http://www.otcmarkets.com/stock/LGNXZ/chart
Company Info http://www.otcmarkets.com/stock/LGNXZ/company-info
Recent News http://www.otcmarkets.com/stock/LGNXZ/news
Financials http://www.otcmarkets.com/stock/LGNXZ/financials
Filings and Disclosure http://www.otcmarkets.com/stock/LGNXZ/filings
Short Sales http://www.otcmarkets.com/stock/LGNXZ/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/LGNXZ/insider-transactions
Research Reports http://www.otcmarkets.com/stock/LGNXZ/research
Summary http://finance.yahoo.com/q?s=LGNXZ
Historical Prices http://finance.yahoo.com/q/hp?s=LGNXZ+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=LGNXZ
Basic Chart http://finance.yahoo.com/q/bc?s=LGNXZ+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNXZ+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=LGNXZ+Headlines
Press Releases http://finance.yahoo.com/q/p?s=LGNXZ+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=LGNXZ+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=LGNXZ+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=LGNXZ+Industry
Major Holders http://finance.yahoo.com/q/mh?s=LGNXZ+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=LGNXZ+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=LGNXZ+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=LGNXZ
Balance Sheet http://finance.yahoo.com/q/bs?s=LGNXZ
Cash Flow http://finance.yahoo.com/q/cf?s=LGNXZ+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/LGNXZ
Market Watch http://www.marketwatch.com/investing/stock/LGNXZ
Bloomberg http://www.bloomberg.com/quote/LGNXZ:US
Morningstar http://quotes.morningstar.com/stock/s?t=LGNXZ
Bussinessweek http://investing.businessweek.com/research/st...cker=LGNXZ
Barchart http://www.barchart.com/quotes/stocks/LGNXZ
OTC Short Report http://otcshortreport.com/index.php?index=LGNXZ
Investopedia http://www.investopedia.com/markets/stocks/LGNXZ/?wa=0